Use of the Trypanosoma cruzi recombinant complement regulatory protein to evaluate therapeutic efficacy following treatment of chronic chagasic patients.
about
Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up StudiesSpecific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review.Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives.Posttherapeutic cure criteria in Chagas' disease: conventional serology followed by supplementary serological, parasitological, and molecular tests.Development and Application of an ELISA Assay Using Excretion/Secretion Proteins from Epimastigote Forms of T. cruzi (ESEA Antigens) for the Diagnosis of Chagas DiseaseTowards a paradigm shift in the treatment of chronic Chagas disease.Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review.The utility of anti-trypomastigote lytic antibodies for determining cure of Trypanosoma cruzi infections in treated patients: an overview and perspectives.Secretome analysis of Trypanosoma cruzi by proteomics studies.Accidental infection by Trypanosoma cruzi follow-up by the polymerase chain reaction: case report.Course of serological tests in treated subjects with chronic Trypanosoma cruzi infection: A systematic review and meta-analysis of individual participant data
P2860
Q26782118-78A76DA4-9B9E-488F-A937-81B267EDEF20Q33631293-91C63A50-DF48-47E4-BF00-17AFF68AEC7CQ34992879-E2DD283D-3290-479D-B68C-F042F78BF826Q35810790-264C6324-5FAF-4E97-87F6-90C90DB23467Q36154765-FC506463-F9E4-489A-AE71-CB63D5F524F3Q36294254-E385F051-5617-45D1-97DB-2F20733D2B8CQ37544885-AF80CD0A-F82D-4198-9139-508B91B6A6B4Q38195336-EE7D09F6-A87C-4D00-A58D-2DFD1147705CQ39945097-4CDDF7AB-A839-4DED-8647-849F3B8F3C11Q42369579-FE75A7A4-4FF8-48B1-BB96-930824C56C11Q43247383-FFEB8073-F65C-4853-BE65-E9407C737061Q56889017-8C83FB8E-F3B7-4488-85B3-CD9ED2963CD6
P2860
Use of the Trypanosoma cruzi recombinant complement regulatory protein to evaluate therapeutic efficacy following treatment of chronic chagasic patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Use of the Trypanosoma cruzi r ...... of chronic chagasic patients.
@ast
Use of the Trypanosoma cruzi r ...... of chronic chagasic patients.
@en
type
label
Use of the Trypanosoma cruzi r ...... of chronic chagasic patients.
@ast
Use of the Trypanosoma cruzi r ...... of chronic chagasic patients.
@en
prefLabel
Use of the Trypanosoma cruzi r ...... of chronic chagasic patients.
@ast
Use of the Trypanosoma cruzi r ...... of chronic chagasic patients.
@en
P2093
P2860
P1476
Use of the Trypanosoma cruzi r ...... of chronic chagasic patients.
@en
P2093
Egler Chiari
Eliane D Gontijo
George L L Machado-Coelho
Karen A Norris
Lúcia M C Galvão
Wendell S F Meira
P2860
P304
P356
10.1128/JCM.42.2.707-712.2004
P407
P577
2004-02-01T00:00:00Z